Full-Time

Software Engineer 2

Quantitative Imaging

Confirmed live in the last 24 hours

Eikon Therapeutics

Eikon Therapeutics

201-500 employees

Biotech startup developing innovative medicines

AI & Machine Learning
Biotechnology

Compensation Overview

$128k - $139.7kAnnually

+ Bonus + Equity Compensation

Junior, Mid

Hayward, CA, USA

Hybrid schedule acceptable; willingness to relocate to the Bay Area.

Category
Backend Engineering
Software QA & Testing
Software Engineering
Required Skills
Python
Pandas
NumPy
C/C++
Requirements
  • Typically requires a Bachelor’s degree and a minimum of 2 years of related experience; or an advanced degree without experience; or equivalent work experience.
  • Prior experience working with and analyzing scientific datasets is essential.
  • Expertise in scientific Python programming (numpy, pandas) is required; additional experience with a strongly typed language (particularly C++) is desirable.
  • Knowledge of biology at the introductory college level is required; exposure to biological/biophysical imaging, imaging hardware, and/or image analysis is strongly preferred.
  • Proficiency in software development best practices (version control, testing, etc.) is required.
  • Excellent verbal and written communication skills.
  • Team-oriented, flexible, and able to adapt to rapidly evolving goals and challenges.
  • Willingness to relocate to the Bay Area (hybrid schedule acceptable).
  • Enthusiasm for gaining drug discovery experience is essential.
Responsibilities
  • Collaborate with scientists, hardware engineers, and other stakeholders to conduct in-depth analyses of proprietary imaging-based and biophysical datasets in support of advancing scientific and technical initiatives.
  • Contribute to the development of novel algorithmic solutions for complex biophysical problems, leveraging image analysis, physics-based simulations, and related methodologies.
  • Guide software solutions through the technical life cycle, from proof-of-concept to production, while adhering to engineering best practices as these solutions mature.
  • Work closely with scientists and engineers to understand tactical needs and develop software solutions that ensure the continuity of experiments.
  • Manage multiple projects simultaneously, establishing milestones and deadlines in alignment with broader company objectives.

Eikon Therapeutics develops new medicines in the pharmaceutical industry by studying biological systems to identify drug targets. They utilize a proprietary single-molecule tracking platform to visualize protein movements in living cells, combined with artificial intelligence and automation for precise molecular interaction analysis. Their diverse team integrates various scientific and engineering disciplines to create therapies aimed at improving the lives of patients with serious diseases. Eikon stands out from competitors by focusing on the dynamic aspects of biology rather than static chemical processes.

Company Stage

Series C

Total Funding

$750.8M

Headquarters

Hayward, California

Founded

2019

Growth & Insights
Headcount

6 month growth

7%

1 year growth

14%

2 year growth

62%
Simplify Jobs

Simplify's Take

What believers are saying

  • Eikon's recent acquisition of global rights to clinical-stage assets and a robust drug development pipeline positions it for significant growth and market impact.
  • The company's strategic partnerships, such as with Impact Therapeutics for PARP1 selective inhibitors, enhance its capabilities in developing targeted cancer therapies.
  • Eikon's expansion into a new 36,284-square-foot office space in Jersey City reflects its growth and commitment to scaling operations.

What critics are saying

  • The highly competitive biotech and pharmaceutical sectors require continuous innovation to maintain a competitive edge.
  • The integration of newly acquired assets and technologies may pose challenges in terms of operational alignment and resource allocation.

What makes Eikon Therapeutics unique

  • Eikon Therapeutics leverages proprietary single-molecule tracking (SMT) technology to visualize protein motion in living cells, setting it apart from competitors who rely on static snapshots of chemical processes.
  • The integration of advanced automation and artificial intelligence allows Eikon to inventory molecular interactions with unprecedented scale and precision.
  • Eikon's diverse team of scientists, engineers, and clinicians enables a multidisciplinary approach to drug development, enhancing innovation and problem-solving capabilities.

Help us improve and share your feedback! Did you find this helpful?